Igm Biosciences Inc (IGMS)

Stock price, financials, and technical signals for Igm Biosciences Inc (IGMS).

$1.16

-0.07

(-5.69%)

As of 04/03/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

IGMS Performance Snapshot


1-Week Chg

-9.38%

1-Month Chg

-7.94%

3-Month Chg

-82.32%

6-Month Chg

-92.21%

1-Year Chg

-87.15%

Year-To-Date Chg

-81.32%

Beta 1-Year

3.06

Beta 5-Year

0.52

Volatility (10-Day)

3.81%

IGMS Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-03

$1.16

-$0.07 (-5.69%)

$1.19

$1.23

$1.14

$1.18

109.91K ($127.49K)

2025-04-02

$1.23

$0.08 (6.96%)

$1.12

$1.23

$1.12

$1.19

135.04K ($166.10K)

2025-04-01

$1.15

$0 (0%)

$1.15

$1.21

$1.11

$1.16

251.80K ($289.57K)

2025-03-31

$1.15

-$0.09 (-7.26%)

$1.19

$1.20

$1.12

$1.16

245.93K ($282.82K)

2025-03-28

$1.24

-$0.04 (-3.13%)

$1.26

$1.30

$1.22

$1.25

124.92K ($154.90K)

2025-03-27

$1.28

$0.05 (4.07%)

$1.25

$1.30

$1.23

$1.27

115.55K ($147.90K)

2025-03-26

$1.23

-$0.03 (-2.38%)

$1.25

$1.26

$1.17

$1.22

94.97K ($116.81K)

2025-03-25

$1.26

$0 (0%)

$1.26

$1.27

$1.22

$1.25

157.09K ($197.93K)

2025-03-24

$1.26

$0.07 (5.88%)

$1.20

$1.26

$1.17

$1.23

172.85K ($217.79K)

2025-03-21

$1.19

-$0.01 (-0.83%)

$1.19

$1.22

$1.15

$1.19

240.37K ($286.05K)

IGMS Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $26.66M

    -76.43%

  • Total assets

    $265.71M

    -37.24%

  • Total liabilities

    $217.54M

    -1.20%

  • Total investments

    $157.29M

    -30.14%

  • Shareholders' equity

    $48.17M

    -76.30%

  • Book value per share

    $0.79

    -76.65%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $412.00K

    -36.71%

  • Net income

    -$36.65M

    39.62%

  • Operating expense

    $39.39M

    -40.11%

  • Gross profit

    $412.00K

    -36.71%

  • EBITDA

    -$33.11M

    41.80%

  • Earnings per share

    -$0.61

    37.76%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    -$16.40M

    73.67%

  • Cash from operations

    -$34.82M

    27.47%

  • Cash from investing

    $18.00M

    222.49%

  • Cash from financing

    $420.00K

    4.48%

  • Free cash flow

    -$35.68M

    27.85%

  • Free cash flow per share

    -$0.59

    28.97%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $363.33M

    -25.13%

  • Enterprise value

    $366.12M

    4.30%

  • Shares outstanding

    59.46M

    1.83%

  • Profit margin

    -8894.90%

    4.59%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -8036.70%

    8.04%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    5.14

    -37.13%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.